Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$156.00 USD

156.00
1,592,815

+0.78 (0.50%)

Updated Aug 1, 2025 03:59 PM ET

After-Market: $155.96 -0.04 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (46 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sridatri Sarkar headshot

BrightSpring's Home Health Arm Soars: What's Powering Growth?

by Sridatri Sarkar

BTSG's Home Health Care Q1 2025 sales surge 21%, fueled by Medicare Advantage gains and high patient satisfaction.

Zacks Equity Research

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for RSPH

Moumi Mondal headshot

CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?

by Moumi Mondal

CVS unveils a $20B digital strategy to tackle healthcare gaps and reshape consumer health experiences.

Zacks Equity Research

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

by Zacks Equity Research

Sector ETF report for FXH

Indrajit Bandyopadhyay headshot

MCK vs. CAH: Which Drug Distribution Giant Has the Healthier Outlook?

by Indrajit Bandyopadhyay

Both McKesson and Cardinal Health dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential.

Zacks Equity Research

Cardinal (CAH) Upgraded to Buy: Here's Why

by Zacks Equity Research

Cardinal (CAH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Should Value Investors Buy Cardinal Health (CAH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Is atai Life Sciences (ATAI) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how atai Life Sciences N.V. (ATAI) and Cardinal Health (CAH) have performed compared to their sector so far this year.

Zacks Equity Research

Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?

by Zacks Equity Research

Sector ETF report for RSPH

Zacks Equity Research

ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues

by Zacks Equity Research

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

Zacks Equity Research

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?

by Zacks Equity Research

Strength in VCYT's Afirma and Decipher tests continues to draw investors' attention.

Zacks Equity Research

Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs

by Zacks Equity Research

Per REFLECT studies, ABT's Libre technology is the first CGM linked to fewer hospitalizations for heart complications in people with diabetes.

Indrajit Bandyopadhyay headshot

MCK Stock Gains More Than 4% Following Strong Q4: Should You Buy Now?

by Indrajit Bandyopadhyay

McKesson's strong fundamentals are likely to keep it ahead of the competition. Should investors add it to their portfolio now?

Zacks Equity Research

Should You Continue to Hold Medtronic Stock in Your Portfolio Now?

by Zacks Equity Research

Investors stay optimistic about MDT due to its strength in the Cardiovascular portfolio.

Zacks Equity Research

Should Edwards Lifesciences Stock Remain in Your Portfolio Now?

by Zacks Equity Research

EW stock is on investors' radars due to the promising structural heart opportunities and impressive TMTT portfolio.

Zacks Equity Research

Omnicell's New Perioperative Clinic Setting Products May Boost Stock

by Zacks Equity Research

OMCL unveils new offerings for the perioperative and clinic setting.

Zacks Equity Research

Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology

by Zacks Equity Research

Cardinal Health, Labcorp and Align Technology have been highlighted in this Industry Outlook article.

Zacks Equity Research

Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now?

by Zacks Equity Research

Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and strategic acquisitions.

Zacks Equity Research

Should You Continue to Retain DGX Stock in Your Portfolio?

by Zacks Equity Research

Quest Diagnostics continues to stay on investors' radars due to its robust Advanced Diagnostics offerings and strength in acquisitions.

Indrajit Bandyopadhyay headshot

3 Dental Supplies Stocks Likely to Gain From US-China Trade Deal

by Indrajit Bandyopadhyay

Here we discuss three stocks from the Dental Supplies industry that are likely to earn wealth for investors. These are CAH, LH and ALGN.

Zacks Equity Research

Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for ONEV

Zacks Equity Research

Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline

by Zacks Equity Research

SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.

Zacks Equity Research

MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off

by Zacks Equity Research

McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.

Zacks Equity Research

Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for ONEV

Zacks Equity Research

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.